NPC Marker Activators
NPC Marker activators form a diverse class of chemicals that modulate the activities of NPC Marker, a protein associated with various cellular processes. These chemicals exert their effects through direct or indirect mechanisms, targeting specific signaling pathways or cellular processes that intricately regulate NPC Marker activation. One group of NPC Marker activators includes compounds that influence intracellular calcium levels. A23187 and Ionomycin, both calcium ionophores, directly impact calcium concentrations, initiating signaling cascades associated with calcium-dependent pathways. NPC Marker, being sensitive to changes in intracellular calcium, responds to these fluctuations, leading to altered cellular responses. This highlights the critical role of calcium signaling in the activation of NPC Marker. Another set of activators focuses on disrupting kinase activities within signaling pathways associated with NPC Marker. For instance, H-89, a protein kinase A (PKA) inhibitor, modulates NPC Marker indirectly by inhibiting PKA, a kinase involved in various signaling cascades. Similarly, SB203580, a p38 MAP kinase inhibitor, targets p38 MAP kinase, influencing downstream signaling events that ultimately impact NPC Marker. The complex interplay between these kinase-dependent pathways and NPC Marker activation is evident in the intricate regulatory network.
The third group of NPC Marker activators includes compounds that directly target protein kinase C (PKC). Compounds like PMA, GF109203X, Bisindolylmaleimide I, Go 6983, and Ro 31-8220 influence NPC Marker by disrupting downstream signaling events associated with PKC-sensitive pathways. This emphasizes the intricate relationship between PKC signaling and the regulation of NPC Marker-mediated cellular responses. Moreover, Wortmannin, a phosphoinositide 3-kinase (PI3K) inhibitor, and KN-93, a CaMKII inhibitor, showcase the involvement of PI3K and CaMKII-dependent pathways in NPC Marker activation. These chemicals disrupt downstream signaling cascades, indirectly affecting NPC Marker and underlining the importance of these pathways in the modulation of NPC Marker-mediated cellular responses.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187, a calcium ionophore, directly influences intracellular calcium levels, triggering signaling cascades associated with calcium-dependent pathways. By modulating calcium signaling, A23187 indirectly impacts NPC Marker activation, as the protein is sensitive to calcium fluctuations, leading to altered cellular responses. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, a phorbol ester, directly activates protein kinase C (PKC), initiating downstream signaling cascades. As NPC Marker is associated with PKC-sensitive pathways, PMA indirectly activates NPC Marker by influencing PKC-mediated cellular responses. The activation of NPC Marker is intricately linked to the modulation of PKC activity through exposure to PMA. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionophore Ionomycin directly impacts intracellular calcium levels, initiating signaling cascades associated with calcium-dependent pathways. NPC Marker activation is influenced indirectly through calcium signaling modulation, as the protein responds to fluctuations in intracellular calcium concentrations, leading to altered cellular responses. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAP kinase inhibitor, directly targets p38 MAP kinase, a key player in stress-activated signaling pathways. By inhibiting p38 MAP kinase, SB203580 influences downstream signaling events, indirectly affecting NPC Marker. This modulation occurs through p38 MAP kinase-dependent pathways, revealing the complex interplay between stress-activated pathways and NPC Marker activation. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I, a PKC inhibitor, directly targets protein kinase C (PKC), inhibiting its activity and disrupting downstream signaling events. Through modulation of PKC-sensitive pathways, Bisindolylmaleimide I indirectly affects NPC Marker activation, revealing the complex interplay between PKC signaling and the regulation of NPC Marker-mediated cellular responses. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a phosphoinositide 3-kinase (PI3K) inhibitor, directly targets PI3K, disrupting downstream signaling cascades associated with PI3K-dependent pathways. By inhibiting PI3K, Wortmannin indirectly influences NPC Marker activation, revealing the complex interplay between PI3K signaling and the regulation of NPC Marker-mediated cellular responses. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Go 6983, a pan-PKC inhibitor, directly inhibits various isoforms of protein kinase C (PKC), disrupting downstream signaling events associated with PKC-sensitive pathways. Through modulation of PKC activity, Go 6983 indirectly affects NPC Marker activation, highlighting the intricate interplay between PKC signaling and NPC Marker-mediated cellular responses. | ||||||
Ro 31-8220 | 138489-18-6 | sc-200619 sc-200619A | 1 mg 5 mg | $92.00 $245.00 | 17 | |
Ro 31-8220, a pan-PKC inhibitor, directly inhibits various isoforms of protein kinase C (PKC), disrupting downstream signaling cascades associated with PKC-sensitive pathways. By modulating PKC activity, Ro 31-8220 indirectly influences NPC Marker activation, revealing the complex interplay between PKC signaling and the regulation of NPC Marker-mediated cellular responses. | ||||||
KN-62 | 127191-97-3 | sc-3560 | 1 mg | $136.00 | 20 | |
KN-62, a CaMK inhibitor, directly inhibits CaMK, a kinase involved in calcium-dependent signaling pathways. By disrupting CaMK activity, KN-62 influences downstream signaling events, indirectly affecting NPC Marker. This modulation occurs through CaMK-dependent pathways, emphasizing the intricate interplay between calcium-dependent signaling and NPC Marker activation. | ||||||